Ruiyun Xu

979 total citations
36 papers, 745 citations indexed

About

Ruiyun Xu is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Ruiyun Xu has authored 36 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 13 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Ruiyun Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver physiology and pathology (10 papers) and Liver Disease and Transplantation (7 papers). Ruiyun Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver physiology and pathology (10 papers) and Liver Disease and Transplantation (7 papers). Ruiyun Xu collaborates with scholars based in China and United States. Ruiyun Xu's co-authors include Nan Lin, Mingxing Xu, Kunpeng Hu, Weidong Pan, Meihai Deng, Yi Lü, Zhicheng Yao, Yanjie Li, Si Chen and Lin Yuan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Hepatology and Life Sciences.

In The Last Decade

Ruiyun Xu

36 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruiyun Xu China 15 334 260 191 187 151 36 745
Aihua Yao China 14 198 0.6× 169 0.7× 219 1.1× 90 0.5× 94 0.6× 29 679
Takehiro Hayashi Japan 15 394 1.2× 279 1.1× 125 0.7× 215 1.1× 178 1.2× 44 937
Di‐Peng Ou China 11 279 0.8× 268 1.0× 126 0.7× 182 1.0× 165 1.1× 14 628
Ágnes Holczbauer United States 14 353 1.1× 201 0.8× 206 1.1× 190 1.0× 69 0.5× 18 727
Yefa Yang China 16 220 0.7× 349 1.3× 138 0.7× 246 1.3× 139 0.9× 39 809
Verena Proell Austria 9 272 0.8× 145 0.6× 61 0.3× 76 0.4× 72 0.5× 9 510
Giulia Orsi Italy 12 171 0.5× 89 0.3× 115 0.6× 113 0.6× 49 0.3× 34 514
Jianhui Qu China 11 234 0.7× 363 1.4× 114 0.6× 166 0.9× 220 1.5× 27 735
M Hisanaga Japan 9 205 0.6× 102 0.4× 218 1.1× 127 0.7× 80 0.5× 37 658
Fumihito Tajima Japan 14 234 0.7× 145 0.6× 107 0.6× 25 0.1× 103 0.7× 29 741

Countries citing papers authored by Ruiyun Xu

Since Specialization
Citations

This map shows the geographic impact of Ruiyun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiyun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiyun Xu more than expected).

Fields of papers citing papers by Ruiyun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiyun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiyun Xu. The network helps show where Ruiyun Xu may publish in the future.

Co-authorship network of co-authors of Ruiyun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiyun Xu. A scholar is included among the top collaborators of Ruiyun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiyun Xu. Ruiyun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xuexian, et al.. (2022). Characteristics of submental muscles function and hyoid bone movement in patients with dysphagia after stroke. Clinical Biomechanics. 100. 105772–105772. 7 indexed citations
2.
Xu, Mingxing, et al.. (2021). Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma. Journal of Translational Medicine. 19(1). 11 indexed citations
3.
Xu, Mingxing, et al.. (2020). Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma. BMC Cancer. 20(1). 313–313. 13 indexed citations
4.
Peng, Hong, Zhiwei Zhou, Yu Guo, et al.. (2019). Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma. EBioMedicine. 46. 105–118. 17 indexed citations
5.
Yao, Zhicheng, Ruiyun Xu, Lin Yuan, et al.. (2019). Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death and Disease. 10(12). 945–945. 97 indexed citations
6.
Xu, Mingxing, et al.. (2018). TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt/β-catenin signaling pathway. Acta Biochimica et Biophysica Sinica. 51(1). 68–77. 34 indexed citations
7.
Zhou, Zheng, et al.. (2017). Associating liver partition and portal vein ligation for staged hepatectomy versus conventional two-stage hepatectomy: a systematic review and meta-analysis. World Journal of Surgical Oncology. 15(1). 227–227. 14 indexed citations
8.
Lin, Nan, Min Zhang, Yong Zhu, et al.. (2015). Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma. Journal of Translational Medicine. 13(1). 365–365. 49 indexed citations
11.
Xu, Ruiyun, Nan Lin, Meihai Deng, et al.. (2013). Effect of transplantation route on stem cell migration to fibrotic liver of rats via cellular magnetic resonance imaging. Cytotherapy. 15(10). 1266–1274. 10 indexed citations
12.
Chen, Wenzhe, Kunpeng Hu, Ruiyun Xu, & Weidong Pan. (2012). Beneficial effect of splenic artery ligation on bacterial translocation after major liver resection in rats. Digestive and Liver Disease. 45(3). 233–237. 2 indexed citations
13.
Xu, Ruiyun. (2011). Precautionary effect on the early application of anticoagulant drugs to portal vein thrombosis in patients with portal hypertension after operation.. China Medical Herald. 1 indexed citations
15.
Pan, Weidong, et al.. (2010). Surgical treatment of complicated hepatolithiasis using the ultrasound-guided fiberoptic choledochoscope. Surgical Endoscopy. 25(2). 497–502. 10 indexed citations
16.
Pan, Weidong, Rongqin Zheng, Nan Lin, et al.. (2009). Ultrasound-Guided Percutaneous Microwave Coagulation Therapy with a “Cooled-tip Needle” for the Treatment of Hepatocellular Carcinoma Adjacent to the Gallbladder. Digestive Diseases and Sciences. 55(9). 2664–2669. 8 indexed citations
17.
Lin, Nan, et al.. (2009). Deficient Proliferation of Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Chronic Hepatitis B Viral Infections and Cirrhosis of the Liver. Digestive Diseases and Sciences. 55(2). 438–445. 24 indexed citations
18.
Lin, Nan, et al.. (2009). Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells. Life Sciences. 85(7-8). 291–295. 50 indexed citations
19.
Deng, Meihai, et al.. (2008). A Novel Canine Model of Esophageal Varices with a Balloon Dilatation Constrictor. Digestive Diseases and Sciences. 54(7). 1449–1455. 4 indexed citations
20.
Xu, Ruiyun, Bo Liu, & Nan Lin. (2004). Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension. World Journal of Gastroenterology. 10(7). 1072–1072. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026